InterCure Expands Strategic Partnership with Cookies to Germany

31 Aug, 2024

InterCure Expands Strategic Partnership with Cookies to Germany

InterCure is expanding its European presence with a new strategic partnership with Cookies, the globally recognized cannabis brand. This agreement will see the launch of Cookies Corners licensed pharmacies in Germany, as well as differentiated online platforms offering the official Cookies retail experience. InterCure will cultivate, manufacture, import, and distribute Cookies-branded products from its facilities, initially through 8 licensed pharmacies in Germany. This expansion also covers the UK, Austria, and Germany, alongside existing collaborations in Israel.

Under this agreement, InterCure will produce Cookies’ licensed genetics and products at its EU-GMP manufacturing sites. These products, including next-generation offerings like live resin and live rosin, will be distributed through Cookies Corners and online platforms. The new partnership comes in the wake of Germany’s "CanG" Cannabis Act, which has significantly increased the number of medical cannabis prescriptions in the country.

Cookies is renowned for its premium cannabis products and rapidly growing international presence. The partnership with InterCure aims to deliver high-quality cannabinoid therapeutics to European markets, leveraging Cookies’ retail experience and InterCure's established infrastructure in pharmaceutical cannabis.

Alexander Rabinovitch, CEO of InterCure, expressed enthusiasm about the expansion into Germany and its potential impact on the European cannabis market. Parker Berling, President of Cookies, highlighted the significance of this partnership in advancing cannabis legalization and bringing Cookies' unique offerings to European patients.